Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

245.80
+5.322.21%
Pre-market: 251.255.45+2.22%07:00 EDT
Volume:422.91K
Turnover:103.85M
Market Cap:15.96B
PE:16.80
High:246.73
Open:244.60
Low:244.04
Close:240.48
52wk High:266.38
52wk Low:123.88
Shares:64.91M
Float Shares:62.69M
Volume Ratio:0.77
T/O Rate:0.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.63
EPS(LYR):-5.8403
ROE:22.11%
ROA:6.86%
PB:3.32
PE(LYR):-42.09

Loading ...

May 02, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2024

Major Issues Report

Form 8-K - Current report
Apr 26, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Mar 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2024

Major Issues Report

Form 8-K - Current report
Feb 27, 2024

Major Issues Report

Form 8-K - Current report
Feb 21, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 25, 2024

Major Issues Report

Form 8-K - Current report
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Dec 15, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Sep 12, 2023

Major Issues Report

Form 8-K - Current report
Sep 12, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Sep 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 29, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities